AI Science Tracker
EN

Data Science Team, Saigeware Inc., Karnataka 560070, India

1 discovery from 2024

Discoveries

Machine Learning-Based Prediction of Readmission Risk in Cardiovascular and Cerebrovascular Conditions Using Patient EMR Data

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: XGBoost predicts readmission-time classes from a large Mayo EHR cohort and is compared with LACE+; reported evidence is retrospective and internally split.

Technology: XGBoost model for readmission-time classification

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
XGBoost model for readmission-time classification
Limitation / still unknown
The study reports evaluation in the stated cohort, samples, datasets, or engineering setting; performance and practical benefit beyond that evaluated setting remain unknown.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11311788/ · https://doi.org/10.3390/healthcare12151497

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.